Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $26.89B | $24.34B | +10.47% |
Cost of Revenue | $9.06B | $9.75B | -7.03% |
Operating Income | $6.36B | $4.95B | +28.56% |
Net Income | $6.38B | $3.46B | +84.18% |
EPS (Basic) | $11.86 | $6.45 | +83.88% |
EPS (Diluted) | $11.77 | $6.40 | +83.91% |
SG&A Expense | $5.1B | $5.22B | -2.30% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $90.14B | $90.88B | -0.82% |
Current Assets | $27.89B | $26.77B | +4.18% |
Current Liabilities | $21.79B | $20.31B | +7.28% |
Stockholders' Equity | $9.62B | $7.53B | +27.79% |
Cash & Equivalents | $9.45B | $9.01B | +4.82% |
Long-Term Debt | $54.59B | $60.4B | -9.62% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $8.36B | $6.72B | +24.35% |
Investing Cash Flow | $-1.25B | $-644M | -94.10% |
Financing Cash Flow | $-9.63B | $-8.01B | -20.29% |
D&A | $4.04B | $4.2B | -3.81% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 23.7% | 20.3% | +3.33% |
Net Margin | 23.7% | — | — |
ROE | 66.3% | — | — |
ROA | 7.1% | — | — |
Current Ratio | $1.28 | — | — |
Other companies in Biotechnology